Yointy 625 Mg Hard Capsules
Out of date information, search anotherPACKAGE LEAFLET: INFORMATION FOR THE USER
Yointy 625 mg hard capsules
Glucosamine
Read all of this leaflet carefully before you start taking this medicine.
- Keep this leaflet. You may need to read it again.
- If you have further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
In this leaflet:
1. What Yointy 625 mg hard capsules is and what it is used for
2. Before you take Yointy 625 mg hard capsules
3. How to take Yointy 625 mg hard capsules
4. Possible side effects
5. How to store Yointy 625 mg hard capsules
6. Further information
The name of this medicine is Yointy 625 mg hard capsules. However the product will be referred to as Yointy within the text of the leaflet.
1. WHAT Yointy IS AND WHAT IT IS USED FOR
Yointy belongs to the group of medicines called other antiinflammatory and anti-rheumatic agents, non-steroids.
Yointy is used to relieve the symptoms in mild to moderate osteoarthritis of the knee.
2. BEFORE YOU TAKE Yointy Do not take Yointy
- if you are allergic (hypersensitive) to glucosamine or to any of the other ingredients of Yointy.
- if you are allergic (hypersensitive) to shellfish, as glucosamine is obtained from shellfish.
Take special care with Yointy
- if your suffer from diabetes mellitus or impaired glucose tolerance. More frequent controls of your blood glucose levels may be necessary when starting treatment with Yointy.
- if you have a known risk factor for cardiovascular disease (e.g. hypertension, diabetes mellitus, raised cholesterol or if you smoke). It is recommended to control your cholesterol before starting treatment with Yointy, since raised cholesterol has been observed in a few cases in patients treated with glucosamine.
- if you suffer from asthma. When starting on glucosamine, you should be aware of potential worsening of symptoms.
- if you have impaired kidney or liver function, since no studies with glucosamine have been performed in this patient group.
Taking other medicines
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
It is particularly important to tell your doctor or pharmacist if you are taking any of the following medicines: -tetracyclines (antibacterials used against infection).
-warfarin or similar type of products (anticoagulants used to prevent blood-clotting). The effect of the anticoagulant may be increased in association with glucosamine. Patients treated with such combinations should therefore be monitored extra carefully when initiating or ending glucosamine therapy.
Taking Yointy with food and drink
Yointy could be taken before, during or after a meal.
Pregnancy and breast-feeding
Ask your doctor or pharmacist for advice before taking any medicine.
Yointy should not be used during pregnancy.
The use of Yointy is not recommended during breastfeeding.
Driving and using machines
No studies on the effects on the ability to drive and use machines have been performed. If you experience dizziness or drowsiness from the capsules, you should not drive or operate machinery.
3. HOW TO TAKE Yointy
Always take Yointy exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.
The usual dose is 2 capsules once daily (1250 mg glucosamine).
Swallow the hard capsules together with some water or other suitable liquid. Do not chew the capsules.
Use in children
Yointy is not recommended for the use in children below 18 years.
Glucosamine is not indicated for the treatment of acute pain. Relief of symptoms (especially pain relief) may not happen for several weeks and sometimes longer. If there is no benefit after 2-3 months, please tell your doctor.
If you take more Yointy than you should
If you have taken too many Yointy capsules you must contact your doctor or nearest hospital.
If you forget to take Yointy
Do not take a double dose to make up for a forgotten dose. If it is almost time for your next dose, skip the forgotten dose and carry on taking Yointy as scheduled.
If you stop taking Yointy
Your symptoms may reoccur.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, Yointy can cause side effects, although not everybody gets them. These are usually mild and transient.
The following side effects have been reported:
Common (occur in less than 1 in 10 but more than 1 in 100 patients):
Headache, tiredness, feeling sick, abdominal pain, indigestion, diarrhoea, constipation.
Uncommon (occur in less than 1 in 100 but more than 1 in 1000 patients):
Rash, itching, flushing
Frequency not known (can not be estimated from available data)
Vomiting, urticaria, dizziness, swelling of the feet or ankles, angioedema. Aggravation of pre-existing asthma, blood glucose control worsened in diabetic patients.
Elevated cholesterol levels have been also reported. It is not possible to determine whether these events were directly related to glucosamine.
If any of the side effects get serious or worsen, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
5. HOW TO STORE Yointy
Keep out of the reach and sight of children.
Do not store above 30°C. Store in the original package to protect from moisture.
Do not use Yointy after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
6. FURTHER INFORMATION What Yointy contains
- The active substance is glucosamine. Each capsule contains 625 mg of glucosamine (equivalent to 750 mg of glucosamine hydrochloride).
- The other ingredient is magnesium stearate.
Capsule composition: gelatin, red iron oxide (E172), titanium dioxide (E171), black iron oxide (E172). What Yointy looks like and contents of the pack Yointy are brown coloured hard gelatine capsules.
Yointy is delivered in a cardboard box containing 60 and 180 capsules in blister packs.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
BIOIBERICA S.A.,
Ctra. Nacional II, Km. 680,6 08389 Palafolls (Barcelona)
Spain.
Manufacturer
J.URIACH&Cia, S.A. Av. Cami Reial 51-57 08184 Palau Solita i Plegamans (Barcelona)
This leaflet was last approved in: 01/2012
Detailed information on this medicine is available on the web site of MHRA http://www.mhra.gov.uk
5